These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33415015)

  • 1. Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic features.
    Shi R; Chen W; Yang B; Qu J; Cheng Y; Zhu Z; Gao Y; Wang Q; Liu Y; Li Z; Qu X
    Am J Cancer Res; 2020; 10(12):4513-4526. PubMed ID: 33415015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
    Yang L; Dong D; Fang M; Zhu Y; Zang Y; Liu Z; Zhang H; Ying J; Zhao X; Tian J
    Eur Radiol; 2018 May; 28(5):2058-2067. PubMed ID: 29335867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Learning Features Improve the Performance of a Radiomics Signature for Predicting KRAS Status in Patients with Colorectal Cancer.
    Wu X; Li Y; Chen X; Huang Y; He L; Zhao K; Huang X; Zhang W; Huang Y; Li Y; Dong M; Huang J; Xia T; Liang C; Liu Z
    Acad Radiol; 2020 Nov; 27(11):e254-e262. PubMed ID: 31982342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases.
    Qu H; Zhai H; Zhang S; Chen W; Zhong H; Cui X
    Front Oncol; 2023; 13():992096. PubMed ID: 36814812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT radiomics models are unable to predict new liver metastasis after successful thermal ablation of colorectal liver metastases.
    Taghavi M; Staal FC; Simões R; Hong EK; Lambregts DM; van der Heide UA; Beets-Tan RG; Maas M
    Acta Radiol; 2023 Jan; 64(1):5-12. PubMed ID: 34918955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases.
    Taghavi M; Trebeschi S; Simões R; Meek DB; Beckers RCJ; Lambregts DMJ; Verhoef C; Houwers JB; van der Heide UA; Beets-Tan RGH; Maas M
    Abdom Radiol (NY); 2021 Jan; 46(1):249-256. PubMed ID: 32583138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between clinicopathological features and
    Zhu X; Meng X; Xiang W; Dai W; Bai Q; Sheng W; Lu Y; Qi P; Wu L; Cai G; Zhou X
    Int J Clin Exp Pathol; 2018; 11(5):2839-2845. PubMed ID: 31938404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-Based Radiomics to Predict
    Porto-Álvarez J; Cernadas E; Aldaz Martínez R; Fernández-Delgado M; Huelga Zapico E; González-Castro V; Baleato-González S; García-Figueiras R; Antúnez-López JR; Souto-Bayarri M
    Biomedicines; 2023 Jul; 11(8):. PubMed ID: 37626641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
    Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
    J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Genetic Mutation Status in Patients with Colorectal Cancer Liver Metastases Using Radiomics-Based Machine-Learning Models.
    Wesdorp N; Zeeuw M; van der Meulen D; van 't Erve I; Bodalal Z; Roor J; van Waesberghe JH; Moos S; van den Bergh J; Nota I; van Dieren S; Stoker J; Meijer G; Swijnenburg RJ; Punt C; Huiskens J; Beets-Tan R; Fijneman R; Marquering H; Kazemier G; On Behalf Of The Dutch Colorectal Cancer Group Liver Expert Panel
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of CT radiomics model in assessing the microsatellite instability of colorectal cancer liver metastasis.
    Wang Y; Ma L; Guo H; Wang X; Ye Z; Fan S; Gao B; Yin XP
    Curr Med Imaging; 2023 Aug; ():. PubMed ID: 37622558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features and prognostic value of KRAS, NRAS and BRAF mutations and DNA mismatch repair status: A single-center retrospective study of 1,834 Chinese patients with Stage I-IV colorectal cancer.
    Guo TA; Wu YC; Tan C; Jin YT; Sheng WQ; Cai SJ; Liu FQ; Xu Y
    Int J Cancer; 2019 Sep; 145(6):1625-1634. PubMed ID: 31162857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed Tomography-Based Radiomic Features Could Potentially Predict Microsatellite Instability Status in Stage II Colorectal Cancer: A Preliminary Study.
    Fan S; Li X; Cui X; Zheng L; Ren X; Ma W; Ye Z
    Acad Radiol; 2019 Dec; 26(12):1633-1640. PubMed ID: 30929999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable Performance of Deep Learning-Based to Manual-Based Tumor Segmentation in KRAS/NRAS/BRAF Mutation Prediction With MR-Based Radiomics in Rectal Cancer.
    Zhang G; Chen L; Liu A; Pan X; Shu J; Han Y; Huan Y; Zhang J
    Front Oncol; 2021; 11():696706. PubMed ID: 34395262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of influencing factors of KRAS/NRAS/BRAF/PIK3CA gene mutation consistency in patients with advanced colorectal cancer].
    Jiang HQ; Wang BL; Guo W
    Zhonghua Yi Xue Za Zhi; 2021 Feb; 101(6):400-404. PubMed ID: 33611888
    [No Abstract]   [Full Text] [Related]  

  • 17. Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.
    Nakayama I; Shinozaki E; Matsushima T; Wakatsuki T; Ogura M; Ichimura T; Ozaka M; Takahari D; Suenaga M; Chin K; Mizunuma N; Yamaguchi K
    BMC Cancer; 2017 Jan; 17(1):38. PubMed ID: 28068936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast MR-Based Radiomics and Machine Learning Analysis to Assess Clinical Outcomes following Liver Resection in Colorectal Liver Metastases: A Preliminary Study.
    Granata V; Fusco R; De Muzio F; Cutolo C; Setola SV; Dell' Aversana F; Ottaiano A; Avallone A; Nasti G; Grassi F; Pilone V; Miele V; Brunese L; Izzo F; Petrillo A
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of MRI Radiomics for Predicting KRAS Mutation in Rectal Cancer.
    Guo XF; Yang WQ; Yang Q; Yuan ZL; Liu YL; Niu XH; Xu HB
    Curr Med Sci; 2020 Dec; 40(6):1156-1160. PubMed ID: 33428144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study.
    Wojas-Krawczyk K; Kalinka-Warzocha E; Reszka K; Nicoś M; Szumiło J; Mańdziuk S; Szczepaniak K; Kupnicka D; Lewandowski R; Milanowski J; Krawczyk P
    Adv Clin Exp Med; 2019 Jan; 28(1):67-73. PubMed ID: 30085422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.